샘플 요청 목록

 카트 문의
시장보고서
상품코드
1886053

세계의 소수성 상호작용 크로마토그래피 시장

Hydrophobic Interaction Chromatography
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 소수성 상호작용 크로마토그래피 시장은 2030년까지 7억 1,630만 달러에 달할 전망

2024년에 4억 9,590만 달러로 추정되는 세계의 소수성 상호작용 크로마토그래피 시장은 2024년부터 2030년까지의 분석 기간 동안 CAGR 6.3%로 성장하여 2030년까지 7억 1,630만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석 대상이 된 부문 중 하나인 수지는 7.3%의 CAGR을 기록하며 분석 기간 종료까지 2억 6,310만 달러에 달할 것으로 예측됩니다. 완충액 부문의 성장률은 분석 기간 동안 6.3%의 CAGR로 추정됩니다.

미국 시장은 1억 2,890만 달러로 추정되는 한편 중국은 CAGR 9.6%로 성장할 것으로 예측됩니다

미국의 소수성 상호작용 크로마토그래피 시장은 2024년에 1억 2,890만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년까지의 분석 기간 동안 CAGR 9.6%를 기록하며 2030년까지 1억 7,020만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장 분석으로는 일본과 캐나다가 있으며, 분석 기간 동안에 각각 CAGR 3.2%, 5.8%로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 3.7%의 CAGR로 성장할 것으로 예측됩니다.

세계의 소수성 상호작용 크로마토그래피 시장 - 주요 동향과 촉진요인 개요

소수성 상호작용 크로마토그래피는 단백질 정제 및 바이오의약품의 게임 체인저가 될 수 있을까?

소수성 상호작용 크로마토그래피(HIC)는 단백질 정제에 있어 중요한 기술인데, 왜 바이오의약품 개발, 생화학 연구, 산업적 단백질 생산에 있어 이토록 중요한 것일까? 소수성 상호작용 크로마토그래피는 소수성을 기반으로 단백질, 펩타이드 및 기타 생체분자를 분리 및 정제하는 강력한 방법입니다. HIC에서는 생체분자를 소수성 고정상을 포함하는 크로마토그래피 컬럼에 적용합니다. 연구자들은 이동상의 염 농도를 조작하여 단백질이 소수성 표면에 결합하거나 용출되는 방식을 제어할 수 있어 복잡한 혼합물을 정밀하게 분리할 수 있습니다.

HIC의 의의는 단백질을 변성시키지 않고 정제할 수 있다는 점에 있으며, 이는 생물학적 활성을 유지하는 데 매우 중요합니다. 이러한 특성으로 인해 HIC는 치료용 단백질, 항체, 기타 생체분자를 정제해야 하는 바이오 제약 산업에서 우선적으로 채택되는 기술입니다. HIC는 특히 다운스트림 공정에서 효과를 발휘하며, 재조합 단백질이나 단클론항체에서 불순물이나 오염물질을 제거하는 데 사용됩니다. 소수성 상호작용 크로마토그래피는 복잡한 생체분자를 정제하는 신뢰할 수 있고 효율적인 방법을 제공함으로써 의약품 개발, 진단, 연구에 필수적인 고순도 단백질 생산에 핵심적인 역할을 하고 있습니다.

기술 발전은 생명공학 및 제약 분야에서 소수성 상호작용 크로마토그래피를 어떻게 향상시켰는가?

기술 발전으로 소수성 상호작용 크로마토그래피는 현대 바이오의약품 및 연구 응용 분야에서 더욱 효과적이고 확장 가능하며 적응력이 뛰어난 방법으로 크게 향상되었습니다. 주요 발전 중 하나는 최적화된 소수성 리간드를 가진 고성능 수지 및 고정상 개발입니다. 이 수지는 결합 특이성과 용량을 향상시켜 소수성이 다른 단백질을 보다 효율적으로 분리할 수 있습니다. 현대의 HIC 수지는 더 높은 해상도를 제공하며, 단백질 동형체 및 항체 변종과 같이 밀접하게 관련된 생체분자를 정제할 수 있습니다. 이는 순도가 최우선시되는 바이오치료제 생산에 있어 매우 중요한 요소입니다.

HIC 기술의 또 다른 중요한 발전은 특정 생체분자에 맞게 고정상의 소수성을 조절할 수 있다는 점입니다. 수지 화학의 발전으로 리간드의 종류와 밀도를 변경하여 소수성 정도를 조절할 수 있게 되었고, 연구자들은 분리 공정을 미세하게 조정할 수 있게 되었습니다. 이러한 유연성은 소수성의 미세한 차이가 최종 제품의 효능에 영향을 미치는 단클론항체 정제 등의 응용 분야에서 특히 유용합니다. 맞춤형 HIC 수지는 단백질을 온화한 조건에서 정제하고 천연 입체 구조와 생물학적 활성을 유지하도록 보장합니다. 이는 치료용 단백질에 있어 매우 중요합니다.

자동화 HIC 시스템도 주요 기술 발전으로 등장하여 크로마토그래피 프로세스의 효율성과 재현성을 향상시키고 있습니다. 자동화 시스템을 통해 유속, 염분 농도 구배, 컬럼 충전량을 정밀하게 제어할 수 있어 분리 공정이 고도로 관리되고 재현성이 높습니다. 자동화는 인적 오류와 변동을 줄이고 제품 순도의 균일성이 매우 중요한 대규모 바이오의약품 생산에 필수적입니다. HIC의 자동화 시스템 통합은 바이오 제조의 다운스트림 공정을 간소화하여 보다 빠르고 확장 가능한 단백질 정제 워크플로우를 실현했습니다.

소수성 상호작용을 이온 교환 및 친 화성 크로마토그래피와 같은 다른 분리 기술과 결합한 혼합 모드 크로마토그래피의 발전으로 HIC의 적용 범위가 더욱 확대되었습니다. 이러한 하이브리드 기법을 통해 전하, 소수성 등 여러 특성에 기반한 생체분자의 동시 분리가 가능합니다. 혼합 모드 HIC는 융합 단백질, 항체약물접합체(ADC), 기타 다기능 치료제와 같은 복잡한 생물학적 제제의 정제에 특히 유용하다는 것이 입증되었습니다. 이러한 발전은 보다 견고하고 유연한 정제 공정을 실현하여 정제 단계 수를 줄이고 전체 바이오프로세싱의 효율성을 향상시켰습니다.

HIC 조건의 최적화를 가속화하기 위해 하이스루풋 스크리닝 방법도 개발되었습니다. 이러한 방법을 통해 연구자들은 여러 가지 수지 유형, 완충액 조건, 염분 농도 구배를 병렬적으로 신속하게 평가할 수 있으며, 특정 생체분자를 정제하기 위한 최적의 설정을 파악할 수 있습니다. 하이스루풋 기술은 시간과 자원의 효율성이 매우 중요한 신약개발 초기 단계에서 특히 가치가 있습니다. 이러한 기술은 조건 최적화 과정을 가속화함으로써 바이오의약품 제품을 시장에 빠르게 출시하는 동시에 높은 순도와 품질을 보장하는 데 기여합니다.

또 다른 중요한 진전은 실험실 규모의 정제에서 대규모 산업 생산까지 쉽게 적응할 수 있는 확장 가능한 HIC 플랫폼의 개발입니다. 이러한 확장성은 정제된 단백질이나 항체를 대량으로 생산해야 하는 바이오의약품 제조에서 특히 중요하며, 스케일업 시에도 성능을 유지할 수 있는 크로마토그래피 시스템이 요구됩니다. 확장 가능한 HIC 수지와 시스템은 연구 단계에서 상업 생산 단계로 원활하게 전환할 수 있으며, 생산량에 관계없이 정제 공정의 일관성과 신뢰성을 보장합니다.

소수성 상호작용 크로마토그래피가 단백질 정제 및 바이오의약품 생산에 중요한 이유는 무엇인가?

소수성 상호작용 크로마토그래피가 단백질 정제 및 바이오의약품 생산에서 매우 중요한 이유는 소수성 상호작용을 기반으로 생체분자를 분리하는 독특한 방법을 제공하면서 단백질의 자연 구조와 기능을 보존하기 때문입니다. HIC가 특히 중요한 이유 중 하나는 단백질을 변성 또는 비활성화시킬 수 있는 가혹한 조건에 노출시키지 않고도 단백질을 정제할 수 있다는 점입니다. 많은 단백질, 특히 바이오의약품에 사용되는 단백질은 온도, pH, 이온 강도의 변화에 민감합니다. HIC는 비교적 온화한 조건에서 작동하며, 정제 과정 전반에 걸쳐 단백질의 안정성을 유지하는 수계 완충액 시스템을 사용합니다. 이는 생물학적 활성을 유지해야 하는 치료용 단백질의 정제에 이상적인 기술입니다.

또한, HIC는 암, 자가면역질환 등 다양한 질환의 치료에 널리 사용되는 단클론항체(mAb)의 정제에도 매우 중요한 역할을 합니다. 단클론항체는 숙주 세포 단백질, DNA, 공정 유래 불순물 등의 오염물질이 포함되지 않도록 하기 위해 고도의 특이적인 정제 과정이 필요한 경우가 많습니다. HIC는 응집체, 단편 및 기타 비정상적인 접힌 단백질로부터 항체를 분리하는 데 특히 효과적이며, 고순도 바이오 치료제를 생산할 수 있도록 보장합니다. HIC가 제공하는 정확성은 항체의 다운스트림 공정에서 필수적인 부분이며, 이러한 약물의 안전성과 유효성에 기여하고 있습니다.

HIC는 치료용 단백질과 항체 외에도 백신 성분, 효소, 기타 바이오의약품의 정제에도 사용됩니다. HIC가 소수성의 미묘한 차이에 따라 단백질을 분리하는 능력은 재조합 단백질 생산과 같이 고순도 분리가 필요한 경우에 특히 유용합니다. 많은 재조합 단백질은 박테리아나 효모와 같은 숙주 세포 내에서 발현되기 때문에 숙주 세포 단백질 및 기타 불순물이 포함된 복잡한 혼합물로부터 분리해야 합니다. HIC는 표적 분자의 활성을 유지하면서 불필요한 성분을 제거하여 이들 단백질을 효율적으로 정제할 수 있는 방법을 제공합니다.

HIC가 바이오의약품 제조에 필수적인 또 다른 이유는 다른 크로마토그래피 기술과의 호환성입니다. 바이오 공정에서는 원하는 순도 수준을 달성하기 위해 여러 크로마토그래피 공정을 연속적으로 사용하는 경우가 많습니다. HIC는 친 화성 크로마토그래피 및 이온 교환 크로마토그래피와 같은 초기 정제 단계의 후공정으로 제품의 추가 정제를 위해 널리 사용됩니다. 다른 기술을 보완할 수 있는 HIC는 특정 생체분자에 맞게 조정할 수 있는 강력한 정제 전략을 구축할 수 있는 다재다능한 도구가 될 수 있습니다. HIC를 다른 정제 방법과 통합함으로써 제조업체는 더 높은 수율, 더 나은 순도 및 더 효율적인 생산 공정을 달성할 수 있습니다.

연구 개발에서 HIC는 단백질의 특성 평가 및 구조 분석에 중요한 역할을 합니다. 이 기술은 단백질의 소수성 및 소수성 표면과의 상호작용을 분석하는 데 사용할 수 있으며, 단백질의 접힘, 안정성, 기능에 대한 귀중한 인사이트를 제공합니다. 이러한 연구 결과는 신약개발에 있어 매우 중요하며, 치료용 단백질이 다양한 조건에서 보이는 거동을 이해함으로써 보다 효과적인 치료법을 설계하는 데 도움을 줄 수 있습니다. 소수성을 기반으로 한 단백질 분리 능력은 단백질 간 상호작용, 응집 경향, 번역 후 변형의 영향을 연구하는 데에도 유용한 도구가 될 수 있습니다.

산업 응용 분야에서는 엄격한 품질 관리가 요구되는 단백질, 효소, 기타 생물학적 제제의 대규모 정제에 HIC가 활용되고 있습니다. HIC 시스템은 확장성과 고순도 제품을 안정적으로 생산할 수 있는 능력으로 인해 바이오의약품의 상업적 생산에 필수적인 존재입니다. 생물학적 제제에 대한 수요가 지속적으로 증가하는 가운데, HIC는 최종 제품의 안전성과 유효성을 유지하면서 생산 수요를 충족시킬 수 있는 효율적이고 신뢰할 수 있는 방법을 제공합니다. 제품의 품질과 일관성을 보장하는 역할은 바이오의약품의 규제 준수와 시장 승인에 있어 매우 중요합니다.

소수성 상호작용 크로마토그래피 시장의 성장을 이끄는 요인은 무엇인가?

소수성 상호작용 크로마토그래피 시장의 급속한 성장을 이끄는 요인은 여러 가지가 있습니다. 여기에는 바이오의약품에 대한 수요 증가, 단백질 기반 의약품 개발의 발전, 의료 치료에서 생물학적 제제에 대한 관심 증가 등이 포함됩니다. 주요 촉진요인 중 하나는 고순도 단백질, 항체, 백신에 대한 수요가 증가하고 있는 바이오의약품 산업의 확대입니다. 생물학적 제제는 특히 암, 자가면역질환, 감염성 질환의 치료에서 의약품 개발의 중요한 초점 영역이 되고 있습니다. 이러한 생물학적 제제 생산에는 정밀하고 효율적인 정제 공정이 필요하기 때문에 HIC 시스템에 대한 수요가 증가하고 있습니다.

다양한 질환 치료에서 단클론항체의 채택 확대도 HIC 시장을 견인하는 중요한 요소입니다. 단클론항체는 치료제 중 가장 빠르게 성장하고 있는 카테고리 중 하나이며, 그 제조에는 안전성과 유효성을 보장하기 위한 엄격한 정제가 요구됩니다. HIC는 단클론항체를 불순물, 응집체, 불필요한 형태로부터 분리하는 정제에 중요한 역할을 하며, 제조에 필수적인 도구가 되고 있습니다. 항체 기반 치료제 시장이 지속적으로 확대됨에 따라 HIC의 수요도 그에 따라 증가할 것으로 예상됩니다.

항체약물접합체(ADC), 융합 단백질, 바이오시밀러 등 바이오의약품 제품의 복잡성이 증가하고 있는 것도 소수성 상호작용 크로마토그래피 시장의 성장에 기여하고 있습니다. 이러한 복잡한 생물학적 제제는 서로 다른 분자 형태를 확실하게 분리하고 원하는 순도 수준을 달성하기 위해 고도의 정제 전략이 필요합니다. HIC는 소수성을 기반으로 단백질과 생체분자를 분리할 수 있어 이러한 첨단 치료제의 정제에 이상적인 기술입니다. 바이오 제약 기업이 새로운 종류의 생물학적 제제를 지속적으로 혁신하고 개발함에 따라 HIC는 생산에서 점점 더 중요한 역할을 할 것입니다.

크로마토그래피 수지 및 시스템의 기술적 진보가 HIC 시장의 성장을 더욱 가속화하고 있습니다. 보다 효율적인 대용량 수지의 개발로 단백질 정제의 분해능과 속도가 향상되어 HIC는 산업 응용 분야에서 더욱 효과적이고 확장성이 높은 기술이 되었습니다. 또한, 자동화 시스템 도입으로 수작업의 개입이 줄어들고 재현성이 향상되어 HIC는 기업에서 보다 쉽게 이용할 수 있게 되었습니다. 이러한 기술 혁신으로 인해 HIC는 대형 바이오의약품 제조업체와 의약품 개발에 종사하는 중소 바이오테크놀러지 기업 모두에게 더욱 매력적인 선택지가 되고 있습니다.

바이오시밀러(이미 승인된 생물학적 제제와 매우 유사한 바이오의약품)의 등장도 HIC와 같은 효율적인 정제 기법에 대한 수요를 견인하고 있습니다. 바이오시밀러 제조업체들이 제품의 품질과 안전성을 유지하면서 비용 효율적인 제조 공정을 추구하고 있는 가운데, HIC는 고순도 단백질 생산을 보장하는 신뢰할 수 있는 솔루션을 제공합니다. 세계 시장에서 바이오시밀러의 승인과 채택이 증가함에 따라 HIC 시스템에 대한 수요는 증가할 것으로 예상됩니다.

마지막으로, 바이오의약품에 대한 규제 요건은 제품의 순도와 품질에 더 많은 중요성을 부여하고, 고도의 정제 기술의 필요성을 높이고 있습니다. 미국 식품의약국(FDA), 유럽의약품청(EMA) 등 규제 당국은 바이오의약품 제조업체에 엄격한 순도 기준을 충족하는 제품을 입증할 것을 요구하고 있습니다. HIC는 이러한 기준을 달성하기 위한 견고하고 신뢰할 수 있는 기술로 널리 인정받고 있으며, 바이오 제조 공정의 중요한 구성요소로 자리매김하고 있습니다.

생물학적 치료에 대한 수요 증가, 바이오 제약 산업의 성장, 단백질 정제 기술의 발전으로 소수성 상호작용 크로마토그래피 시장은 지속적으로 확대될 것으로 예상됩니다. 바이오 제약사들이 정제 워크플로우의 최적화와 고순도 제품의 효율적인 생산을 추구하는 가운데, HIC는 차세대 생물학적 제제 생산에 필수적인 도구로 자리매김할 것입니다.

부문:

제품/서비스(수지, 컬럼, 완충액, 기타 제품/서비스), 샘플(단클론항체, 백신, 기타 샘플)

조사 대상 기업 예시

  • Avantor Performance Materials LLC
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • GE Healthcare Life Sciences
  • Geno Technology Inc.
  • JNC Corporation
  • Knauer GmbH
  • Merck KgaA
  • Mitsubishi Chemical Corporation
  • Sartorius AG
  • Sepax Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Waters Corporation

AI 통합

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보를 혁신하고 있습니다.

Market Glass, Inc.는 LLM이나 산업 특화형 SLM을 쿼리하는 일반적인 방식이 아닌, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색 엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁 변화를 예측하면서 지리적 시장에 대한 관세의 영향을 반영하였습니다. 이러한 복잡하고 다면적인 시장 현실은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사에게 다양한 영향을 미치며, 미시적 및 거시적 시장 역학에도 영향을 미칩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM

Global Hydrophobic Interaction Chromatography Market to Reach US$716.3 Million by 2030

The global market for Hydrophobic Interaction Chromatography estimated at US$495.9 Million in the year 2024, is expected to reach US$716.3 Million by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Resins, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$263.1 Million by the end of the analysis period. Growth in the Buffers segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$128.9 Million While China is Forecast to Grow at 9.6% CAGR

The Hydrophobic Interaction Chromatography market in the U.S. is estimated at US$128.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$170.2 Million by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Hydrophobic Interaction Chromatography Market - Key Trends and Drivers Summarized

Is Hydrophobic Interaction Chromatography the Game-Changer for Protein Purification and Biopharmaceuticals?

Hydrophobic interaction chromatography (HIC) is a vital technique in protein purification, but why is it so critical for biopharmaceutical development, biochemical research, and industrial protein production? Hydrophobic interaction chromatography is a powerful method used to separate and purify proteins, peptides, and other biomolecules based on their hydrophobicity. In HIC, biomolecules are applied to a chromatography column that contains a hydrophobic stationary phase. By manipulating the salt concentration in the mobile phase, researchers can control how proteins bind to or elute from the hydrophobic surface, allowing for precise separation of complex mixtures.

The significance of HIC lies in its ability to purify proteins without denaturing them, which is crucial for maintaining their biological activity. This makes HIC a preferred technique in the biopharmaceutical industry, where proteins, antibodies, and other biomolecules need to be purified for therapeutic use. HIC is particularly effective in downstream processing, where it is used to remove impurities and contaminants from recombinant proteins and monoclonal antibodies. By providing a reliable and efficient method for purifying complex biomolecules, hydrophobic interaction chromatography is central to the production of high-purity proteins essential for drug development, diagnostics, and research.

How Have Technological Advancements Improved Hydrophobic Interaction Chromatography for Biotech and Pharma?

Technological advancements have significantly enhanced hydrophobic interaction chromatography, making it more effective, scalable, and adaptable for modern biopharmaceutical and research applications. One of the key advancements has been the development of high-performance resins and stationary phases with optimized hydrophobic ligands. These resins improve binding specificity and capacity, allowing for more efficient separation of proteins with varying degrees of hydrophobicity. Modern HIC resins offer greater resolution, enabling the purification of closely related biomolecules, such as protein isoforms and antibody variants, which is critical in the production of biotherapeutics where purity is paramount.

Another important development in HIC technology is the ability to tailor the hydrophobicity of the stationary phase to suit specific biomolecules. Advances in resin chemistry have made it possible to adjust the degree of hydrophobicity by modifying ligand types and densities, allowing researchers to fine-tune the separation process. This flexibility is especially valuable in applications like monoclonal antibody purification, where slight variations in hydrophobicity can impact the final product’s efficacy. Tailored HIC resins ensure that proteins are purified under mild conditions, preserving their native conformation and biological activity, which is crucial for therapeutic proteins.

Automated HIC systems have also emerged as a major technological advancement, improving the efficiency and reproducibility of the chromatography process. Automated systems allow for precise control of flow rates, salt gradients, and column loading, ensuring that the separation process is highly controlled and reproducible. Automation reduces human error and variability, which is essential in large-scale biopharmaceutical production where consistency in product purity is critical. The integration of HIC into automated systems has streamlined downstream processing in biomanufacturing, allowing for faster and more scalable protein purification workflows.

Advancements in mixed-mode chromatography, which combines hydrophobic interaction with other separation techniques like ion exchange or affinity chromatography, have further expanded the applications of HIC. These hybrid approaches allow for the simultaneous separation of biomolecules based on multiple characteristics, such as charge and hydrophobicity. Mixed-mode HIC has proven especially useful in purifying complex biologics like fusion proteins, antibody-drug conjugates (ADCs), and other multimodal therapeutic agents. This advancement provides a more robust and flexible purification process, reducing the number of purification steps and enhancing overall efficiency in bioprocessing.

High-throughput screening methods have also been developed to accelerate the optimization of HIC conditions. These methods allow researchers to quickly evaluate multiple resin types, buffer conditions, and salt gradients in parallel, identifying the optimal settings for purifying a particular biomolecule. High-throughput techniques are particularly valuable in early-stage drug development, where time and resource efficiency are critical. By speeding up the process of condition optimization, these techniques help bring biopharmaceutical products to market faster while ensuring high levels of purity and quality.

Another significant advancement is the development of scalable HIC platforms that can be easily adapted from laboratory-scale purification to large-scale industrial production. This scalability is particularly important in biopharmaceutical manufacturing, where the need to produce large quantities of purified proteins or antibodies requires chromatography systems that maintain performance as they scale up. Scalable HIC resins and systems allow for a seamless transition from research to commercial production, ensuring that the purification process remains consistent and reliable, regardless of the production volume.

Why Is Hydrophobic Interaction Chromatography Critical for Protein Purification and Biopharmaceutical Production?

Hydrophobic interaction chromatography is critical for protein purification and biopharmaceutical production because it offers a unique method of separating biomolecules based on hydrophobic interactions while preserving the native structure and function of proteins. One of the main reasons HIC is so important is its ability to purify proteins without subjecting them to harsh conditions that could denature or deactivate them. Many proteins, especially those used in biopharmaceuticals, are sensitive to changes in temperature, pH, or ionic strength. HIC operates under relatively mild conditions, using aqueous buffer systems that maintain protein stability throughout the purification process. This makes it an ideal technique for purifying therapeutic proteins that need to retain their biological activity.

HIC is also crucial for the purification of monoclonal antibodies (mAbs), which are widely used in the treatment of various diseases, including cancer and autoimmune disorders. Monoclonal antibodies often require highly specific purification processes to ensure that they are free from contaminants such as host cell proteins, DNA, and process-related impurities. HIC is particularly effective in separating antibodies from aggregates, fragments, and other forms of misfolded proteins, ensuring the production of high-purity biotherapeutics. The precision offered by HIC makes it a vital part of the downstream processing of antibodies, contributing to the safety and efficacy of these drugs.

In addition to therapeutic proteins and antibodies, HIC is also used in the purification of vaccine components, enzymes, and other biopharmaceuticals. The ability of HIC to separate proteins based on subtle differences in hydrophobicity is particularly valuable in cases where high-purity separation is needed, such as in the production of recombinant proteins. Many recombinant proteins are expressed in host cells like bacteria or yeast, where they must be isolated from a complex mixture of host cell proteins and other impurities. HIC provides an efficient way to purify these proteins, removing unwanted components while maintaining the activity of the target molecule.

Another reason HIC is essential for biopharmaceutical production is its compatibility with other chromatographic techniques. In bioprocessing, multiple chromatography steps are often used in sequence to achieve the desired level of purity. HIC is commonly used after initial purification steps such as affinity chromatography or ion exchange chromatography to further refine the product. Its ability to complement other techniques makes HIC a versatile tool for building robust purification strategies that can be tailored to specific biomolecules. By integrating HIC with other purification methods, manufacturers can achieve higher yields, greater purity, and more efficient production processes.

In research and development, HIC plays a key role in protein characterization and structural studies. The technique can be used to analyze the hydrophobicity of proteins and their interaction with hydrophobic surfaces, providing valuable insights into protein folding, stability, and function. These insights are critical for drug discovery and development, where understanding the behavior of therapeutic proteins under different conditions can guide the design of more effective treatments. HIC’s ability to separate proteins based on hydrophobicity also makes it a valuable tool for studying protein-protein interactions, aggregation tendencies, and the effects of post-translational modifications.

In industrial applications, HIC is used for the large-scale purification of proteins, enzymes, and other biologics that require stringent quality control. The scalability of HIC systems, along with their ability to consistently produce high-purity products, makes them indispensable in the commercial production of biopharmaceuticals. As the demand for biologic drugs continues to grow, HIC provides an efficient and reliable method for meeting production needs while maintaining the safety and efficacy of the final product. Its role in ensuring product quality and consistency is critical for regulatory compliance and market approval of biopharmaceuticals.

What Factors Are Driving the Growth of the Hydrophobic Interaction Chromatography Market?

Several factors are driving the rapid growth of the hydrophobic interaction chromatography market, including the increasing demand for biopharmaceuticals, advancements in protein-based drug development, and the growing focus on biologics in medical treatments. One of the primary drivers is the expanding biopharmaceutical industry, where the need for high-purity proteins, antibodies, and vaccines is growing. Biologics have become a key area of focus in drug development, particularly in therapies for cancer, autoimmune diseases, and infectious diseases. As the production of these biologics requires precise and efficient purification processes, the demand for HIC systems is rising.

The growing adoption of monoclonal antibodies in the treatment of various medical conditions is another significant factor driving the HIC market. Monoclonal antibodies are among the fastest-growing classes of therapeutic drugs, and their production requires rigorous purification to ensure safety and efficacy. HIC plays a critical role in purifying monoclonal antibodies by separating them from impurities, aggregates, and unwanted forms, making it an indispensable tool in their manufacturing. As the market for antibody-based therapies continues to expand, the demand for HIC is expected to rise accordingly.

The increasing complexity of biopharmaceutical products, such as antibody-drug conjugates (ADCs), fusion proteins, and biosimilars, is also contributing to the growth of the hydrophobic interaction chromatography market. These complex biologics require sophisticated purification strategies to ensure the separation of different molecular forms and achieve the desired purity levels. HIC’s ability to resolve proteins and biomolecules based on their hydrophobicity makes it an ideal technique for purifying these advanced therapeutics. As biopharmaceutical companies continue to innovate and develop new classes of biologic drugs, HIC will play an increasingly important role in their production.

Technological advancements in chromatography resins and systems are further fueling the growth of the HIC market. The development of more efficient and high-capacity resins has improved the resolution and speed of protein purification, making HIC more effective and scalable for industrial use. In addition, the integration of automated systems has made HIC more accessible to companies by reducing manual intervention and improving reproducibility. These technological innovations are making HIC a more attractive option for both large-scale biopharmaceutical manufacturers and smaller biotech firms engaged in drug development.

The rise of biosimilars-biopharmaceutical products that are highly similar to already-approved biologics-is also driving demand for efficient purification methods like HIC. As biosimilar manufacturers seek to develop cost-effective production processes while maintaining the quality and safety of their products, HIC offers a reliable solution for ensuring high-purity protein production. With the growing approval and adoption of biosimilars in global markets, the demand for HIC systems is expected to increase.

Lastly, regulatory requirements for biopharmaceuticals are placing greater emphasis on product purity and quality, driving the need for advanced purification technologies. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require biopharmaceutical manufacturers to demonstrate that their products meet stringent purity standards. HIC is widely recognized as a robust and reliable technique for achieving these standards, making it a critical component of the biomanufacturing process.

With the rising demand for biologic therapies, the growth of the biopharmaceutical industry, and advancements in protein purification technologies, the hydrophobic interaction chromatography market is poised for continued expansion. As biopharmaceutical companies seek to optimize their purification workflows and produce high-purity products efficiently, HIC will remain an essential tool in the production of next-generation biologics.

SCOPE OF STUDY:

The report analyzes the Hydrophobic Interaction Chromatography market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product & Services (Resins, Columns, Buffers, Other Product & Services); Sample (Monoclonal Antibodies, Vaccines, Other Samples)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 11 Featured) -

  • Avantor Performance Materials LLC
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • GE Healthcare Life Sciences
  • Geno Technology Inc.
  • JNC Corporation
  • Knauer GmbH
  • Merck KgaA
  • Mitsubishi Chemical Corporation
  • Sartorius AG
  • Sepax Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Waters Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Hydrophobic Interaction Chromatography - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Biopharmaceutical Purification and Separation Drives Growth in Hydrophobic Interaction Chromatography Market
    • Expansion of Protein and Antibody-based Therapeutics Spurs Adoption of Hydrophobic Interaction Chromatography
    • Growth in Focus on Improving Protein Separation and Purification Efficiency Expands Addressable Market for Hydrophobic Interaction Chromatography
    • Role of Hydrophobic Interaction Chromatography in Enhancing Downstream Bioprocessing Strengthens Business Case for Adoption
    • Increasing Focus on Chromatography Solutions for Monoclonal Antibodies and Vaccines Fuels Market Demand
    • Increasing Focus on Chromatography Solutions for Gene Therapy and Viral Vector Production Expands Addressable Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hydrophobic Interaction Chromatography Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Resins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Resins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Resins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Columns by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Columns by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Columns by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Buffers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Product & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Product & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Product & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Monoclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • JAPAN
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • CHINA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • EUROPE
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • FRANCE
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • GERMANY
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • INDIA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Hydrophobic Interaction Chromatography by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030
  • AFRICA
    • Hydrophobic Interaction Chromatography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Hydrophobic Interaction Chromatography by Product & Services - Resins, Columns, Buffers and Other Product & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Hydrophobic Interaction Chromatography by Product & Services - Percentage Breakdown of Value Sales for Resins, Columns, Buffers and Other Product & Services for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hydrophobic Interaction Chromatography by Sample - Monoclonal Antibodies, Vaccines and Other Samples Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Hydrophobic Interaction Chromatography by Sample - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Vaccines and Other Samples for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제